How People Try to Beat Drug Testing and Defend Positive Results
|
By Kim Scott (AACC) Posted on 12 Jul 2022 |

Image: How People Try to Beat Drug Testing and Defend Positive Results (Photo courtesy of aacc.org)
Drug abuse is a critical problem throughout the world. While opioids are a significant public health concern, accounting for 2.88 million visits to emergency departments in the U.S. in 2016 and 2017, other drugs are also abused on a regular basis, including cocaine, amphetamines, and benzodiazepines.
In 1986, President Reagan directed federal agencies to achieve a drug-free work environment. Many private employers also employ drug testing to ensure their workplaces are safe. Approximately 20 million people are screened each year in the U.S. in workplace drug testing programs, said Amitava Dasgupta, PhD, professor of pathology and laboratory medicine at the University of Kansas Medical Center in Kansas City.
Dasgupta will discuss ways that people try to beat drug tests and strategies clinical laboratories can use to detect adulterated specimens during a roundtable session “How People Try to Beat Drug Testing and Defend Positive Results” at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo on July 24-28 in Chicago.
About 2% of people undergoing drug testing attempt to “beat” the tests, Dasgupta said. Some people try to beat drug tests by ingesting detoxifying agents designed to flush out drugs and metabolites. Others add adulterants to their urine, such as common household chemicals –laundry bleach, table salt, toilet bowl cleaner, and vinegar. While these types of adulterants are fairly easy to identify, there are chemicals that can be purchased online that are more difficult to identify in urine. In addition, some individuals purchase synthetic urine online in an attempt to beat drug tests in settings where collection of a urine specimen is not supervised.
When attempts to beat drug tests fail and a test comes back positive, individuals sometimes blame the positive result on other issues, such as eating food with poppyseeds, inhaling second-hand marijuana smoke, or taking CBD products for pain.
Dasgupta will also discuss ways to debunk common defenses of positive drug tests. “This is a very important topic because we want to have a drug-free workplace, and lab medicine professionals who are involved in the field of toxicology testing play a big role in helping ensure a safe workplace,” he said. “It’s important to know ways in which people can try to beat drug tests so you know what to look out for.”
Among the topics that will be covered during this session:
“There are 14,000 sites on the internet that tell you how to beat a drug test, Dasgupta noted. “My goal is to make sure that toxicologists know how people try to beat tests so they can be prepared in advance.”
In 1986, President Reagan directed federal agencies to achieve a drug-free work environment. Many private employers also employ drug testing to ensure their workplaces are safe. Approximately 20 million people are screened each year in the U.S. in workplace drug testing programs, said Amitava Dasgupta, PhD, professor of pathology and laboratory medicine at the University of Kansas Medical Center in Kansas City.
Dasgupta will discuss ways that people try to beat drug tests and strategies clinical laboratories can use to detect adulterated specimens during a roundtable session “How People Try to Beat Drug Testing and Defend Positive Results” at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo on July 24-28 in Chicago.
About 2% of people undergoing drug testing attempt to “beat” the tests, Dasgupta said. Some people try to beat drug tests by ingesting detoxifying agents designed to flush out drugs and metabolites. Others add adulterants to their urine, such as common household chemicals –laundry bleach, table salt, toilet bowl cleaner, and vinegar. While these types of adulterants are fairly easy to identify, there are chemicals that can be purchased online that are more difficult to identify in urine. In addition, some individuals purchase synthetic urine online in an attempt to beat drug tests in settings where collection of a urine specimen is not supervised.
When attempts to beat drug tests fail and a test comes back positive, individuals sometimes blame the positive result on other issues, such as eating food with poppyseeds, inhaling second-hand marijuana smoke, or taking CBD products for pain.
Dasgupta will also discuss ways to debunk common defenses of positive drug tests. “This is a very important topic because we want to have a drug-free workplace, and lab medicine professionals who are involved in the field of toxicology testing play a big role in helping ensure a safe workplace,” he said. “It’s important to know ways in which people can try to beat drug tests so you know what to look out for.”
Among the topics that will be covered during this session:
- What are common household chemicals that are often used to adulterate urine?
- What are commercially available products used to beat drug tests and how can you recognize when they are being used?
- How can you differentiate natural urine from synthetic urine?
- Protocols for detecting specific adulterants.
- What are common defenses for a positive drug test and how they can be debunked?
“There are 14,000 sites on the internet that tell you how to beat a drug test, Dasgupta noted. “My goal is to make sure that toxicologists know how people try to beat tests so they can be prepared in advance.”
Latest AACC 2022 News
- AACC 2022 Review: International Meetings Rebound After Suffering Long COVID Hiatus
- Faster Method Diagnoses Pediatric Urinary Tract Infections
- Tianlong Showcases Integrated PCR Lab Solutions at AACC 2022
- Cellavision Introduces New Workflow Solution for Low-Volume Hematology Labs at AACC 2022
- Advanced Instruments Introduces New Automated Osmometer at AACC 2022
- Innovative Smartphone and AI-Based Tests Featured at AACC 2022
- New Tests Presented at AACC 2022 to Solve Challenges in Children's Healthcare
- 10-Minute Sepsis Risk Stratification Test Introduced at AACC 2022
- New System Combining DNA/RNA Extraction and Smart PCR Setup Launched at AACC 2022
- Novel Small Volume Blood Collection Device Launched at AACC 2022
- AACC Disruptive Technology Award Finalists Tackle Cancer, Women's Health, and STDs
- Meridian Demonstrates State-of-the-Art Urea Breath Test System at AACC 2022
- Nikon Instruments Displays Latest Clinical Pathology Products at AACC 2022
- Seegene Showcases Latest Molecular Testing Solutions at AACC 2022
- Werfen Introduces New Acute Care Diagnostic Products for CVOR at AACC 2022
- PerkinElmer Demonstrates Vanadis NIPT Screening Platform Featuring Groundbreaking cfDNA Technology
Channels
Clinical Chemistry
view channel
First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage
Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more
Multi-Cancer Blood Test Expands Detection to Cancers Lacking Routine Screening Options
Many lethal cancers lack routine screening and are often diagnosed only after symptoms emerge, limiting curative options. Standard programs in the United States cover a small subset of malignancies, leaving... Read more
Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes
Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read moreMolecular Diagnostics
view channel
CSF Liquid Biopsy Could Help Distinguish Cancer from Autoimmune Brain Inflammation
Autoimmune encephalitis can cause memory and behavioral changes, seizures, and altered consciousness, but diagnosis can be challenging because cancers involving the brain and central nervous system may... Read more
Mpox Analysis Reveals Substantial Suspected False Positives Associated with Contamination
Reliable confirmation of mpox can be difficult where multiple rash-causing illnesses co-circulate and laboratory capacity is limited. Although PCR is central to case detection, contamination during specimen... Read more
Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors
Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read moreHematology
view channel
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read moreImmunology
view channel
Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent
Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more
Blood Biomarker May Predict Colitis Risk in Checkpoint Inhibitor Therapy
Immune checkpoint inhibitors can trigger immune-related colitis that leads to severe diarrhea, abdominal pain, and treatment interruptions. Clinicians currently lack validated tools to identify which patients... Read more
Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead
Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read moreMicrobiology
view channel
Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories
Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more
Study Finds Frequent Overlap in Antibodies to Lyme and Other Tick-Borne Pathogens
Lyme disease and other tick-borne illnesses cause overlapping symptoms, making them difficult to distinguish clinically. The Centers for Disease Control and Prevention estimates that more than 476,000... Read morePathology
view channel
Simple Test Could Reduce the Need for Invasive Uterine Cancer Checks
Bleeding after menopause requires prompt investigation for uterine cancer, although most women who undergo testing do not have the disease. In the U.K., uterine cancer affects nearly 10,000 women each... Read more
Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival
Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more
Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing
Predicting which patients with early-stage breast cancer will develop distant recurrence remains difficult, complicating decisions about long-term therapy and surveillance. Widely used genomic assays are... Read moreTechnology
view channel
ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more
Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more
New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more
Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
Recombinant proteins are central to many cancer diagnostics and therapies, but numerous targets remain difficult and costly to produce because they are unstable, toxic to microbial hosts, or require precise folding.... Read moreIndustry
view channel
New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing
C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Multi-Cancer Early Detection Test Wins FDA Panel Backing for Approval
GRAIL’s Galleri multi-cancer early detection (MCED) test was reviewed by the Molecular and Clinical Genetics Devices Panel of the U.S. Food and Drug Administration’s (FDA) Medical Devices Advisory Committee.... Read more
Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing
Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more








